Mml Investors Services »

Halozyme Therapeutics shares owned by Mml Investors Services

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Mml Investors Services from 13F filings

Historical chart of Mml Investors Services investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mml Investors Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mml Investors Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 18k 1.08

More positions owned by Mml Investors Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Mml Investors Services

Top funds holding Halozyme Therapeutics

Millennium Management
Tenor Capital Management
M&G
Jpmorgan Chase & Co
Nuveen
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
FMR
Point72 Asset Management
Calamos Advisors
MacKay Shields
Angelo, Gordon & Co
Advent Capital Management
Sonora Investment Management Group
Colony
Water Island Capital

View all funds holding Halozyme Therapeutics